Our Services

Clinilabs is a contract research organization (CRO) that provides early phase and specialty clinical drug development services to the
pharmaceutical, biotechnology, and medical device industries. We focus on Phase I and Phase II studies that prepare development
candidates to move forward into Phase III pivotal trials. Working within this niche, Clinilabs adds value to clinical drug development
programs by executing studies that enable clients to make sound decisions regarding the viability of new drug candidates. Our goal is to move acceptable candidates forward swiftly and abandon failures early.